ACE and type 2 diabetes mellitus: Interventional studies have documented that angiotensin converting enzyme (ACE)-inhibitors [39] and angiotensin receptor blockers (ARBs) [40] reduce the incidence of type 2 diabetes mellitus (T2DM).